Hungary vs IDA blend: Cause of death, by non-communicable diseases, female
Hungary
80.5%
in 2021
IDA blend
44.6%
in 2021
Hungary rank
37th
IDA blend rank
39th
Cause of death, by non-communicable diseases, female over time
- Hungary
- IDA blend
How they compare
Hungary currently reports 80.5% against 44.6% in IDA blend, a difference of 35.9%.
That makes Hungary's figure about 1.8 times IDA blend's.
Across all 6 years both countries report, Hungary has been ahead every year.
Hungary ranks 37th and IDA blend ranks 39th of 185 countries.
Hungary has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Hungary | IDA blend | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 93.1% | 29.1% | 64.0% | Hungary |
| 2010s | 94.9% | 41.0% | 53.9% | Hungary |
| 2020s | 85.1% | 44.6% | 40.6% | Hungary |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Hungary or IDA blend?
- Hungary, at 80.5% against 44.6% in IDA blend as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Hungary and IDA blend?
- 35.9%, with Hungary ahead.
- How many years of comparable data are there for Hungary and IDA blend?
- 6 years are reported by both, from 2000 to 2021.
- How do Hungary and IDA blend rank globally for cause of death, by non-communicable diseases, female?
- Hungary ranks 37th and IDA blend ranks 39th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.